Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. (Q37110398)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2009

Language	Label	Description	Also known as
English	Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.	scientific article published on February 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Jeanny B Aragon-Ching

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Yang-Min Ning

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Clara C Chen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lea Latham

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jean-Pierre Guadagnini

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

James L Gulley

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Philip M Arlen

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

John J Wright

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Howard Parnes

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

William D Figg

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

William L Dahut

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 February 2009

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cancer Investigation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

27

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

221-226

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

14 September 2017

Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: a word of caution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Zoledronic acid and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Osteonecrosis of the jaw and bisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Osteonecrosis of the jaws associated with cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648132

3 September 2018

Osteonecrosis after chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteonecrosis of bone associated with combination chemotherapy without corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of ASBMR Task Force on ONJ

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Jaw complications in breast and prostate cancer patients treated with zoledronic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteonecrosis of the jaws: a complication of cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/07357900802208608

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19235596%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37110398&oldid=2175069522"